Leland Gershell - Net Worth and Insider Trading
Leland Gershell Net Worth
The estimated net worth of Leland Gershell is at least $3,801 dollars as of 2024-11-13. Leland Gershell is the CHIEF FINANCIAL OFFICER of Capricor Therapeutics Inc and owns about 210 shares of Capricor Therapeutics Inc (CAPR) stock worth over $3,801. Leland Gershell is also the CFO of Tonix Pharmaceuticals Holding Corp and owns about 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Leland Gershell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Leland Gershell has not made any transactions after 2016-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Leland Gershell
Leland Gershell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leland Gershell owns 2 companies in total, including Capricor Therapeutics Inc (CAPR) , and Tonix Pharmaceuticals Holding Corp (TNXP) .
Click here to see the complete history of Leland Gershell’s form 4 insider trades.
Insider Ownership Summary of Leland Gershell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2016-03-16 | Chief Financial Officer |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2015-09-28 | Chief Financial Officer |
Leland Gershell Latest Holdings Summary
Leland Gershell currently owns a total of 2 stocks. Among these stocks, Leland Gershell owns 210 shares of Capricor Therapeutics Inc (CAPR) as of March 16, 2016, with a value of $3,801 and a weighting of 100%. Leland Gershell also owns 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of September 28, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Leland Gershell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2016-03-16 | 210 | 18.10 | 3,801 |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2015-09-28 | 0 | 0.15 | 0 |
Holding Weightings of Leland Gershell
Leland Gershell Form 4 Trading Tracker
According to the SEC Form 4 filings, Leland Gershell has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 210 shares on March 16, 2016, which cost Leland Gershell around $5,040.
According to the SEC Form 4 filings, Leland Gershell has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on September 28, 2015, which cost Leland Gershell around $2,332.
Insider Trading History of Leland Gershell
- 1
Leland Gershell Trading Performance
GuruFocus tracks the stock performance after each of Leland Gershell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leland Gershell is 64.5%. GuruFocus also compares Leland Gershell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leland Gershell within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leland Gershell's insider trading performs compared to the benchmark.
Performance of Leland Gershell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.85 | | | | | |
| Relative Return to S&P 500(%) | 5.18 | | | | | |
Leland Gershell Ownership Network
Ownership Network List of Leland Gershell
Ownership Network Relation of Leland Gershell
Leland Gershell Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Leland Gershell is the Chief Financial Officer of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Leland Gershell made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 2,798,507 shares, with a net purchase of 2,798,507 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Leland Gershell Mailing Address
Above is the net worth, insider trading, and ownership report for Leland Gershell. You might contact Leland Gershell via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Ste 306, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
